Enanta Pharmaceuticals, Inc. (ENTA)
11.11
-0.17
(-1.51%)
USD |
NASDAQ |
Jun 08, 16:00
11.11
0.00 (0.00%)
After-Hours: 19:28
Enanta Pharmaceuticals Total Liabilities (Quarterly) : 198.12M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arcturus Therapeutics Holdings, Inc. | 54.05M |
| MeiraGTx Holdings Plc | 302.78M |
| Keros Therapeutics, Inc. | 26.66M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 314.70M |
| Shareholders Equity (Quarterly) | 116.59M |
| Debt to Equity Ratio | 1.601 |
| Current Ratio | 3.842 |
| Net Debt Paydown Yield | 1.89% |